ClinicalTrials.gg
RecruitingNCT05867433Updated Oct 5, 2026

Strong Teens for Healthy Schools Change Club: A Civic Engagement Approach to Improving Physical Activity and Healthy Eating Environments

An interventional study of STHS Intervention and Usual Care in Cardiovascular Diseases, Nutrition and Physical Activity, sponsored by Texas A&M University. Recruiting at 1 site in United States. Open to participants aged 8 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by Texas A&M University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Started Sep 2023; still recruiting 3 years 1 month later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
500
Allocation
Randomized
Ages
8 Years and older
Sex
All
01

Study summary

Strong Teens for Healthy Schools (STHS) is a school-based, civic engagement program that empowers middle school students to improve their physical activity and healthy eating behaviors, improve their cardiovascular disease outcomes, and create positive change in their school health environments.

Read the detailed description

The investigators will conduct a cluster-randomized controlled trial to evaluate the impact of the Strong Teens for Healthy Schools (STHS) program on cardiovascular disease-related outcomes. STHS is a multi-level, theory-based civic engagement program to catalyze positive food and physical activity environmental change and improve cardiovascular disease-related health (CVD) outcomes among 6th and 7th-grade students.

Title 1 middle schools in Texas (n=20) with > 40% Hispanic and Black students will be randomized at baseline to the intervention condition (STHS program) or control condition (will continue with usual care, as they will not be asked to add or remove any of their current, physical activity, healthy eating, or positive youth development programming) (n=20-25 students per school).

The investigators hypothesize that students who participate in STHS will have reduced MetS risk, improved positive youth developmental outcomes, and improved social and environmental outcomes immediately post-intervention and one year after study completion compared to students in a control condition.

02

Conditions studied

  • Cardiovascular Diseases
  • Nutrition
  • Physical Activity
03

In context

Cardiovascular Diseases

5,376 studies on the registry are indexed under Cardiovascular Diseases; 940 are open to participants now.

This study's planned enrollment of 500 is above the median of 100 across 3,086 interventional studies indexed under Cardiovascular Diseases.

Browse Cardiovascular Diseases studies →

Lead sponsor

Texas A&M University is the lead sponsor of 124 studies on the registry; 24 are open to participants now.

Of its 7 completed or terminated interventional studies of FDA-regulated products, 2 (29%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
8 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

School Inclusion Criteria:

  • > 50 6th and 7th grade students
  • > 40% economically disadvantaged students
  • > 40% Black and Hispanic students

School Exclusion Criteria:

Student Inclusion Criteria:

  • 6th or 7th grade student
  • Attend a Title 1 middle school that is participating in the STHS intervention
  • Read and understand English

Student Exclusion Criteria:

  • Participation in a weight loss program in the past 3 months
  • Presence of a condition that prevents participation in physical activity
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
500 participants (estimated)

Study arms

  • Experimental
    STHS Intervention

    Participants in this group (10 schools) will participate in the STHS program.

    Behavioral: STHS Intervention

  • Other
    Usual Care

    Participants in this group (10 schools) will continue with usual care, as they will not be asked to add or remove any of their current, physical activity, healthy eating, or positive youth development programming.

    Behavioral: Usual Care

Interventions

  • BehavioralSTHS Intervention

    STHS program The intervention group (10 schools) will participate in the STHS program. During the fall semester (September to December), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that provide education on civic engagement, healthy eating, and physical activity. During the spring semester (February to May), the intervention group will receive 24 thirty-minute modules (or twelve 1-hour modules) that focus on implementing the school health environmental change project and receive support for maintaining individual-level healthy eating and physical activity behaviors.

  • BehavioralUsual Care

    No STHS program The usual care group will be offered the same activities as the intervention group after the conclusion of the research study.

06

What researchers measure

Primary outcomes

  1. Presence or absence of metabolic syndrome (MetS)

    MetS is present after identifying abdominal obesity plus at least two of the four other MetS Risk factors: high blood pressure, high blood sugar, low HDL cholesterol, and high triglyceride levels. MetS = (abdominal obesity) + (2 of 4 other MetS Risk factors) Measures to determine MetS risk factors: 1. Abdominal obesity: waist circumference \>90th percentile for child's sex and age 2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg) 3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes 4. Low HDL cholesterol: HDL cholesterol \<1.03 mmol/L 5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  2. Change in the number of MetS risk factors

    Change in the number of MetS risk factors = (new # of MetS risk factors) - (original # of MetS risk factors) Measures to determine MetS risk factors: 1. Abdominal obesity: waist circumference \>90th percentile for child's sex and age 2. High blood pressure: systolic blood pressure ≥130 mm Hg or diastolic blood pressure ≥90 mmHg) 3. High blood glucose: blood glucose ≥5.6 mmol/L or known diabetes 4. Low HDL cholesterol: HDL cholesterol \<1.03 mmol/L 5. High triglyceride level: Triglyceride level ≥ 1.7mmol/L

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  3. Positive Youth Development score

    Positive youth development will be measured using a 5 C's Model of Positive Youth Development Scale-Short Form (PYD-SF): A 34-item scale that assesses the strength of psychological, behavioral, and social development in youth. The five dimensions measured are: 1. Competence (sense of proficiency) 2. Confidence (self-worth, self-efficacy) 3. Character (adherence to societal and cultural rules) 4. Connection (bonds with people and institutions) 5. Caring (sympathy and empathy towards others)

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

Secondary outcomes

  1. Blood pressure level

    Blood pressure (systolic and diastolic) will be measured with two numbers using an automated Omron sphygmomanometer.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  2. Concentration of blood glucose

    Glucose will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  3. Waist circumference

    Waist circumference will be measured at the midpoint between the floating rib and iliac crest using a tape measure.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  4. Concentration of HDL cholesterol

    HDL-C will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  5. Concentration of serum triglycerides

    Triglycerides will be measured using a portable Cholestech LDX analyzer to assess a single capillary blood sample following an overnight fast.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  6. Height

    Height will be measured using a stadiometer in inches.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  7. Weight

    Weight will be measured with a scale in pounds.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  8. Body mass index (BMI)

    Weight will be measured with a scale, and height will be measured using a stadiometer. BMI will be calculated as BMI = (weight (lb)/height (inches)2) x 703.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  9. Concentration of subdermal carotenoids

    The concentration of subdermal carotenoids will assess the changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  10. Accelerometer-derived physical activity estimation

    Physical activity will be measured using Actigraph accelerometers. Measurements will include light physical activity (PA), moderate PA, moderate to vigorous PA, and vigorous PA.

    Time frame: Baseline to 9 months

  11. Sedentary time

    Sedentary time will be measured using Actigraph accelerometers.

    Time frame: Baseline to 9 months

  12. Time spent sleeping

    Sleep time will be measured using Actigraph accelerometers.

    Time frame: Baseline to 9 months

  13. Physical fitness capacity estimation

    Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness.

    Time frame: Baseline, 9 months (immediate post intervention), 4 months and 12 months post intervention

  14. School physical activity and nutrition environment assessment

    The school's physical activity and nutrition environments will be measured using a self-reported School Environment Survey.

    Time frame: Baseline to 9 months

  15. Assessment of perceptions of school environments and school-specific dietary intake patterns

    Perceptions related to physical activity and nutrition within the school setting will be measured using the Perceptions of the Environment and Patterns of Diet at School (PEA-PODS) survey.

    Time frame: Baseline to 9 months

  16. Assessment of perceived sociopolitical control

    Perceived sociopolitical control will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' perceived sociopolitical control (i.e., participation in advocacy programs and optimism for change).

    Time frame: Baseline to 9 months

  17. Assessment of assertiveness

    Assertiveness will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' assertiveness (i.e., ability to engage with adults and peers).

    Time frame: Baseline to 9 months

  18. Assessment of participatory competence and decision-making

    Participatory competence and decision-making will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' participatory competence and decision-making (i.e., ability to influence group decision-making).

    Time frame: Baseline to 9 months

  19. Assessment of advocacy outcome efficacy

    Advocacy outcome efficacy will be measured using the Youth Engagement and Action for Health (YEAH!) survey. The YEAH survey will be used to assess students' advocacy outcome efficacy (i.e., belief in their ability to work with others to improve the school's physical activity and nutrition environment).

    Time frame: Baseline to 9 months

  20. Peer concentration of subdermal carotenoids

    The concentration of subdermal carotenoids will assess peers' engagement in health behaviors changes in fruit and vegetable consumption using the Veggie Meter: A non-invasive, portable machine that measures subdermal carotenoid levels using resonance Raman spectroscopy.

    Time frame: Baseline to 9 months

  21. Peer Body mass index (BMI)

    Peers' engagement in health behaviors will be measured by the change in peers' BMI. Weight will be measured with a scale, and height will be measured using a stadiometer. Calculate BMI with the formula: BMI = (weight (lb)/height (inches)2) x 703.

    Time frame: Baseline to 9 months

  22. Peer physical fitness capacity estimation

    Peers' engagement in health behaviors will be measured by the change in peers' physical fitness. Physical fitness will be measured using the FitnessGram PACER multistage aerobic capacity test: Children will run back and forth 20 meters, with an initial running speed of 8.5 km/hour and a progressive 0.5-km/hour increase in running speed every minute. As the test continues it becomes progressively harder. The number of laps completed is used to estimate children's physical fitness physical fitness.

    Time frame: Baseline to 9 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Seguin-Fowler RA, Graham ML, Eldridge GD, Folta SC, Szeszulski J, MacMillan Uribe AL, Marshall GA, Villarreal DL, Volpe LC, Maddock JE, Nelson ME. Implementation of and Recommendations From the Change Club Civic Engagement Curriculum Targeting Health Behavior Improvement. Am J Health Promot. 2026 Aug 17:8901171261478393. doi: 10.1177/08901171261478393. Online ahead of print. PubMed 42608888 ↗
  • MacMillan Uribe AL, George A, McNeely A, Xin L, Largacha Cevallos E, Rethorst C, Seguin Fowler RA, Szeszulski J. Strong Teens for Healthy Schools: Protocol for evaluating a youth nutrition, physical activity, and civic engagement protocol. Front Public Health. 2025 Sep 17;13:1654678. doi: 10.3389/fpubh.2025.1654678. eCollection 2025. PubMed 41041380 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2023 (actual). Primary completion is estimated for Apr 2027, 42 months after the start.

Of 1,081 non-industry interventional studies with no phase under Cardiovascular Diseases, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 48. This study's planned 42 months is above that.

Counting every sponsor, half of 1,220 studies reached it within 26 months; a quarter within 12 and three quarters within 49.

Cardiovascular Diseases covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 11, 2023
First posted
May 22, 2023
StartActual
Sep 27, 2023
Primary completionEst.
Apr 15, 2027
CompletionEst.
Apr 15, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Publications
1 publication citing this study linked from PubMed, e.g. PubMed 42608888 ↗
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Publications 1 publication citing this study linked from PubMed, e.g. PubMed 42608888 ↗
    + 2 other changes: verification date and oversight details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT05867433
Responsible party
Sponsor
First posted
May 22, 2023
Start date
Sep 27, 2023
Primary completion
Apr 15, 2027 (estimated)
Completion
Apr 15, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Jacob S Szeszulski, PhD
Contact
jacob.szeszulski@ag.tamu.edu
972-231-5362
Alexandra L MacMillan Uribe, PhD
Contact
lexi.macmillanuribe@ag.tamu.edu
972-952-9275

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion